Johns Hopkins University School of Medicine
Jennifer Elisseeff is the Morton Goldberg Professor and director of the Translational Tissue Engineering Center at Wilmer Eye Institute and the Department of Biomedical Engineering at JHU. In 2004, Elisseeff cofounded Cartilix, Inc, a startup that translated adhesive and biomaterial technologies for treating orthopedic disease, acquired by Biomet Inc in 2009. Also in that year, she founded Aegeria Soft Tissue, a startup focused on soft tissue regeneration and wound healing. She is a member of the National Academy of Inventors (and advises a number of biotech companies around the country). She received a bachelor's degree in chemistry from Carnegie Mellon University and a Ph.D. in medical engineering from the Harvard-MIT Division of Health Sciences and Technology. In 2018, she was elected to the National Academy of Engineering and National Academy of Medicine.